Studies have demonstrated that GSH supplementation may increase serum and liver GSH levels but decrease serum DNA peroxidation product and ALT levels, further assuaging liver damage in patients with nonalcoholic fatty liver disease [29,30]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.